Think of the children when reforming Canada’s drug approval system
By embedding children’s needs more explicitly within regulatory decision-making, we can ensure that medicines proven safe and effective in comparable jurisdictions can reach Canada’s kids faster.
When your child is sick, only one thing matters: access to the right treatment, at the right time, in the right place. For many Canadian families, that certainty is out of reach—not because effective treatments do not exist, but because the regulatory framework underpinnin...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
